Global Markets: The S&P 500 drops, crude gains on upbeat vaccine news, recovery hopes
By Stephen Culp NEW YORK (Reuters) - The S&P 500 and the Nasdaq lost ground on Tuesday and crude oil prices extended the previous session's surge as encouraging prospects of an effective COVID-19 vaccine led investors away from market leaders and toward cyclical stocks associated with economic recovery. The blue-chip Dow, buoyed by industrial shares, was modestly higher and crude advanced as investors bet on rebounding demand. Pfizer Inc's announced on Monday that its COVID-19 vaccine candidate, developed with German partner BioNTech, showed in trials it had a 90% success rate in preventing infection
By Stephen Culp
NEW YORK (Reuters) - The S&P 500 and the Nasdaq lost ground on Tuesday and crude oil prices extended the previous session's surge as encouraging prospects of an effective COVID-19 vaccine led investors away from market leaders and toward cyclical stocks associated with economic recovery.
The blue-chip Dow, buoyed by industrial shares, was modestly higher and crude advanced as investors bet on rebounding demand.
Pfizer Inc's announced on Monday that its COVID-19 vaccine candidate, developed with German partner BioNTech, showed in trials it had a 90% success rate in preventing infection.
The development led to investors taking profits from market-leading tech stocks that have thrived amid the pandemic recession.
But some investors pondered whether the rotation was premature.
"This action your seeing in tech is a sinking ship and the rats are running to the other end," said Robert Pavlik, senior portfolio manager at Dakota Wealth in Fairfield, Connecticut. "I'm amazed by this massive rotation out of what's worked so well in the economic shutdown.
"We've gone through these rotations from growth to value only to it see it fade out real quickly," Pavlik added. "People are saying it's different this time but how many times have we heard that?"
The Dow Jones Industrial Average rose 139.28 points, or 0.48%, to 29,297.25, the S&P 500 lost 20.44 points, or 0.58%, to 3,530.06 and the Nasdaq Composite dropped 212.66 points, or 1.82%, to 11,501.13.
Optimism over a potential vaccine breakthrough helped keep European shares near eight-month highs, but gains were held in check by growing concerns about the depth of economic damage wrought by the pandemic.
The pan-European STOXX 600 index rose 0.81% and MSCI's gauge of stocks across the globe shed 0.28%.
Emerging market stocks lost 1.26%. MSCI's broadest index of Asia-Pacific shares outside Japan closed 0.81% lower, while Japan's Nikkei rose 0.26%.
U.S. Treasury yields slipped on Tuesday in choppy trading, pulling back from steep gains the previous session. But the direction for rates has turned higher amid optimism about the economy with the positive news on a potential coronavirus vaccine.
Benchmark 10-year notes last rose 3/32 in price to yield 0.9476%, from 0.958% late on Monday.
The 30-year bond last rose 11/32 in price to yield 1.7351%, from 1.751% late on Monday.
Oil prices extended Monday's surge, which gave the commodity its biggest daily percentage gain in five months, as views of a possible medical solution to the pandemic outweighed sagging demand from new lockdowns to contain the virus.
U.S. crude rose 1.51% to $40.90 per barrel and Brent was last at $42.94 per barrel, up 1.27% on the day.
Vaccine hopes also helped the dollar inch up against a basket of currencies, as investors quit long positions in other safe-haven currencies such as the Japanese yen and the Swiss franc.
The dollar index rose 0.04%, with the euro up 0.03% to $1.1817.
The Japanese yen strengthened 0.09% versus the greenback at 105.28 per dollar, while Sterling was last trading at $1.3225, up 0.47% on the day.
Gold regained some ground lost in Monday's plunge as market participants bet on continued monetary support from central banks.
Spot gold added 1.1% to $1,882.80 an ounce.
(Reporting by Stephen Culp; additional reporting by Marc Jones; Editing by Dan Grebler)
This story has not been edited by Firstpost staff and is generated by auto-feed.
By Robin Emmott and John Irish | BRUSSELS/PARIS BRUSSELS/PARIS France and Germany will agree to a U.S. plan for NATO to take a bigger role in the fight against Islamic militants at a meeting with President Donald Trump on Thursday, but insist the move is purely symbolic, four senior European diplomats said.The decision to allow the North Atlantic Treaty Organization to join the coalition against Islamic State in Syria and Iraq follows weeks of pressure on the two allies, who are wary of NATO confronting Russia in Syria and of alienating Arab countries who see NATO as pushing a pro-Western agenda."NATO as an institution will join the coalition," said one senior diplomat involved in the discussions. "The question is whether this just a symbolic gesture to the United States
BEIJING Chinese President Xi Jinping on Wednesday called for greater efforts to make the country's navy a world class one, strong in operations on, below and above the surface, as it steps up its ability to project power far from its shores.China's navy has taken an increasingly prominent role in recent months, with a rising star admiral taking command, its first aircraft carrier sailing around self-ruled Taiwan and a new aircraft carrier launched last month.With President Donald Trump promising a US shipbuilding spree and unnerving Beijing with his unpredictable approach on hot button issues including Taiwan and the South and East China Seas, China is pushing to narrow the gap with the U.S. Navy.Inspecting navy headquarters, Xi said the navy should "aim for the top ranks in the world", the Defence Ministry said in a statement about his visit."Building a strong and modern navy is an important mark of a top ranking global military," the ministry paraphrased Xi as saying.